Deal Announcements

Coferon Collects $12 Million VC Financing

Wednesday, July 18, 2012 5:35:00 AM PDT | VentureDeal

Stony Brook, New York  --  Biotechnology company Coferon has secured $12 million in its second round of institutional venture capital funding.

Coferon is attempting to establish a new class of orally bioavailable therapeutic molecules "capable of hitting targets inside the cell with exquisite selectivity."

Investors in the round included Ascent Biomedical Ventures, Hatteras Venture Partners, MedImmune Ventures and others.

Proceeds purposes from the round were not disclosed.

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.
Venturedeal Twitter Venturedeal Facebook Venturedeal Linkedin

PCI - Level1